Randomized
Clinical trials for Randomized explained in plain language.
Never miss a new study
Get alerted when new Randomized trials appear
Sign up with your email to follow new studies for Randomized, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug delay the need for lymphoma treatment?
Disease control Not yet recruitingThis phase 2 trial compares two approaches for people with untreated, low-tumor-burden follicular lymphoma: receiving the investigational drug epcoritamab or being closely monitored without treatment. The goal is to see if epcoritamab can extend the time before standard treatment…
Matched conditions: RANDOMIZED
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New vaginal capsule aims to tackle stubborn bacterial vaginosis
Disease control Not yet recruitingThis study tests a new drug called GenSci142, given as a vaginal capsule, for treating bacterial vaginosis (BV). About 30 women with BV will receive either GenSci142 or a standard antibiotic cream to compare safety and how well each works. The goal is to see if the new capsule is…
Matched conditions: RANDOMIZED
Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC